latest update:
[TrialBase DB]

trial summary · NCT07808346

Investigating Basal Ganglia-Cortical Physiology During Sleep and Its Modulation by Adaptive Deep Brain Stimulation in Parkinson Disease

Trial record from the TrialBase DB dataset, status RECRUITING, condition Parkinson's Disease (PD), sponsored by University of Colorado, Denver. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07808346phase —enrollment 18start 2026-12-01

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

This is an interventional study of a cohort of patients with PD treated with DBS, and already utilizing adaptive DBS (dual threshold mode). In Aim 1, we will obtain baseline sleep and basal ganglia physiology data to inform aDBS parameter changes. Aim 2 involves 15 nights of in-home monitoring of subjective and objective sleep quality, during which participants will use 3 different sleep-tailored aDBS settings at night only. Participant preference among these 3 settings will determined the 'optimized sleep-tailored aDBS mode'. Participants will undergo repeat polysomnography, while in the optimized sleep-tailored aDBS mode, to compare aDBS behavior and sleep architecture to the baseline (Aim 1) sleep study.

Source record: https://clinicaltrials.gov/study/NCT07808346

Facts

registry idNCT07808346
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionParkinson's Disease (PD)
sponsorUniversity of Colorado, Denver
sponsor classOTHER
enrollment18
start date2026-12-01
primary completion2028-07-31
completion2028-07-31
results postednot reported

Conditions

  • Parkinson's Disease (PD)

Interventions

  • adaptive DBS (aDBS)

Countries

  • United States

Intervention types: DEVICE

Work with this record